Site Search
Search Results
Governor Newsom’s Veto of Legislation to Expand Access to Biomarker Testing Fails Cancer Patients
Sacramento , Calif. – Last night, Governor Gavin Newsom vetoed legislation that would have ensured comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which ... American Cancer Society Cancer Action Network (ACS CAN) and the University of California – aimed to enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
Senate Introduces Legislation to Increase Californians’ Access to Lifesaving Testing and Innovative Treatments
Sacramento, Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. The American Cancer Society Cancer Action Network (ACS CAN) and ... Cancer Centers. “Last year, I authored legislation to provide patients diagnosed with stages 3 and 4 cancer with prompt access to biomarker testing to inform their course of treatment. We know there are biomarker testing available for other conditions that can help healthcare ...
California Cancer Advocates Rally Virtually for Increased Access to Innovative Testing and Lifesaving Treatments
... Network (ACS CAN) volunteers met virtually with state lawmakers Tuesday and urged them to pass legislation that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Biomarker testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better ...
California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments
Sacramento, Calif. – June 21, 2022 – The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. If signed into law, Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments
Sacramento, Calif. – The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which ... was introduced by Senator Monique Limón (D-Santa Barbara) – has received unanimous, bipartisan support throughout the legislative process. Biomarker testing is a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
2024 California Legislative Policy Roundtable and Awards
... We will also honor our Legislator of the Year State Senator Monique Limon (CA - SD19) for passage of Senate Bill 912 to improve access to Biomarker testing for Californians. Ways to Support ACS CAN's Impact We invite you to be part of a group of sustaining supporters enabling ACS CAN’s ...
Virtual Policy Forum to Highlight the Role of Research in Equitable Access to High-Quality Cancer Care in California
... all levels of government that reduce disparities in cancer care. Among these are Senate Bill 912, a legislation that would ensure comprehensive biomarker testing is covered by more insurance plans – including Medi-Cal; and the California Cancer Care Equity Act (SB 987), which would ensure ...